Has Raja Nazir, MD received payments from drug or device companies?

Yes. Drug and device makers reported $13,944 in general payments to Raja Nazir, MD across 74 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Raja Nazir, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Raja Nazir, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Raja Nazir, MD

Interventional Cardiology · Wilmington, OHNPI 1003871963

Payments from drug & device makers

$13,944in general payments, 2019–2025

Across 74 payments — averaging $188.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$7K
Penumbra, Inc.$2K
Abbott$2K
Boston Scientific$1K
Abiomed$676
Shockwave Medical, Inc$405
plus $994 from 9 others

$90in research payments, 2019–2025

Across 1 payment — averaging $89.97 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Abiomed$90

What the payments were for

Speaking & faculty fees$1,3139%
Travel & lodging$8,89664%
Food & beverage$3,70627%
Education$290%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	14	$7,159
Penumbra, Inc.	8	$1,823
Abbott	16	$1,780
Boston Scientific	15	$1,107
Abiomed	6	$676
Shockwave Medical, Inc	4	$405
Angiodynamics, Inc.	2	$264
Veryan Medical Incorporated	2	$204
Stryker	1	$155
Impulse Dynamics (USA) Inc.	1	$135
Inari Medical, Inc.	1	$130
Livanova USA, Inc.	1	$73
Amgen	1	$17
Chiesi USA, Inc.	1	$12
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	1	$3

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

CoreValve Evolut$6,351
Indigo System$1,540
AMPLATZER AMULET$994
COREVALVE EVOLUT R$563
GENERAL - THERAPIES$475
Impella$358
Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$316
OPTIMIZER$270
AngioVac$264
MitraClip$163
FlowTriever$155
FLOWTRIEVER CATHETER, S$130
CT THROMBECTOMY SYSTEM KIT$130
BioMimics$129
JETi All In One Non-Sterile Kit$128
NAVITOR$111
GENERAL VASCULAR INTERVENTION$103

How this compares

$13,944 in reported general payments places this provider in the 60th percentile of 256 interventional cardiology providers in Ohio.

See all interventional cardiology providers in Ohio →

Medicare billing

Part B allowed, 2024

$256,768

Medicare patients

885

Services billed

2,541

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	424	$477,233
EntrestoSacubitril/Valsartan	243	$283,042
Repatha SureclickEvolocumab	75	$82,265
XareltoRivaroxaban	65	$66,433
FarxigaDapagliflozin Propanediol	27	$24,757
MultaqDronedarone Hcl	17	$23,447
JardianceEmpagliflozin	14	$17,688
Atorvastatin Calcium	716	$6,193
Rosuvastatin Calcium	585	$5,687
Metoprolol Succinate	568	$5,550
ClopidogrelClopidogrel Bisulfate	606	$5,108
Ranolazine ErRanolazine	44	$4,911
BystolicNebivolol Hcl	14	$4,268
Diltiazem 24hr Er (Cd)Diltiazem Hcl	151	$4,080
Losartan Potassium	568	$3,502

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Wilmington

M Niranjan ReddyWilmington$157K
Santiago GarciaCincinnati$3.6M
Gary AnselColumbus$3.4M
Dean KereiakesCincinnati$3.4M
Steven YakubovColumbus$3.2M
Joseph ChooCincinnati$1.9M
Carlos Sanchez SotoColumbus$1.7M
John CheathamColumbus$1.7M
Brendan DuffyCanton$1.5M
Timothy HenryCincinnati$1.3M

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →